Epitome Therapeutics raises $4.3M Pre-seed (Austria, Jun 2026)

Austrian BioTech startup Epitome Therapeutics announces €4 million in funding to advance programmes and grow team - EU-Startups

Epitome Therapeutics is a BioTech company focused on advancing precision epigenome editing for programmable gene expression. The company aims to develop new therapeutic approaches based on the precise regulation of gene expression, with a notable emphasis on their CADENCE platform. This funding will help them build their team and advance their development programmes.

Austrian BioTech startup Epitome Therapeutics announces €4 million in funding to advance programmes and grow team  EU-Startups